Welcome to our dedicated page for Varex Imaging SEC filings (Ticker: VREX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Varex Imaging Corporation (VREX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a publicly traded Nasdaq issuer. Varex designs and manufactures X-ray imaging components and systems for medical, industrial, and security applications, and its filings offer detailed insight into how this business is reflected in its financial statements, risk factors, and governance disclosures.
Through this page, users can review Varex’s periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which present segment information for the Medical and Industrial businesses, revenue composition, gross margin, operating expenses including research and development, and details on capital structure items like long-term debt and convertible notes. These filings also contain management’s discussion and analysis and other disclosures that complement the high-level figures in press releases.
Current reports on Form 8-K document specific material events. For example, a recent 8-K furnished an earnings press release titled “Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025,” while another 8-K described a transition agreement with the company’s Senior Vice President, Chief Legal Officer, and Corporate Secretary, outlining continued service, compensation, and equity vesting terms. Such filings help investors track both financial performance and key governance changes.
On Stock Titan, VREX filings are updated as they are made available through EDGAR. AI-powered summaries highlight the main points of lengthy documents, helping readers quickly understand topics such as segment performance, non-GAAP reconciliations, debt and liquidity, and executive arrangements. Users can also review ownership and insider activity through forms that report transactions by officers and directors, providing an additional perspective on Varex Imaging Corporation’s regulatory record.
Varex Imaging Corp director Christine A. Tsingos reported the delivery of vested equity awards. On February 9, 2026, 8,483 Deferred Stock Units converted into an equal number of shares of Varex Imaging common stock at an exercise price of $0 per share.
These Deferred Stock Units were originally granted on February 9, 2023, vested on February 8, 2024, and were delivered in stock on the third anniversary of the grant date. After this transaction, Tsingos directly beneficially owns 42,655 shares of Varex Imaging common stock.
Varex Imaging Corp reported an equity award update for its Chief Financial Officer, Shubham Maheshwari, on a Form 4. On 12/15/2025, he was credited with 4,515 performance stock units (PSUs) tied to an award originally granted on December 10, 2023, and 5,520 PSUs tied to an award granted on December 10, 2024, both at an exercise price of $0.
Each PSU represents a contingent right to receive one share of Varex Imaging common stock, based on achieving specified performance criteria. The amounts reported reflect PSUs earned for fiscal year 2025 performance. After the completion of fiscal year 2026 and fiscal year 2027, the Compensation Committee will certify the final number of PSUs earned for the respective grants, and vesting will require that the CFO remains employed through the vesting dates.
Varex Imaging Corp reported an insider equity update for its SVP and GM, Detectors. On 12/15/2025, the executive had performance stock units (PSUs) credited based on fiscal year 2025 results from two previously granted PSU awards.
For a grant awarded on December 10, 2023, 2,565 PSUs were earned for fiscal 2025, and for a grant awarded on December 10, 2024, 3,134 PSUs were earned for the same fiscal year’s performance. Each PSU represents a contingent right to receive one share of Varex Imaging common stock. Final PSU totals for these grants will be certified after fiscal years 2026 and 2027 respectively, and vesting depends on the executive remaining employed through the vesting dates.
Varex Imaging Corp reported an insider equity award update for senior executive Mark S. Jonaitis, who serves as SVP and GM, X-Ray Sources. On December 15, 2025, he acquired performance stock units (PSUs) that each represent a contingent right to receive one share of Varex Imaging common stock, subject to meeting performance goals.
The filing shows 2,565 PSUs tied to an award granted on December 10, 2023 and 3,134 PSUs tied to an award granted on December 10, 2024. In each case, the number reported reflects PSUs earned for fiscal year 2025 based on achievement of specified performance criteria. Final PSU amounts for the 2023 grant will be certified after fiscal 2026, and for the 2024 grant after fiscal 2027, with vesting conditioned on Mr. Jonaitis remaining employed through the vesting dates.
Varex Imaging Corp's President and CEO, who is also a director, reported new performance-based stock unit awards tied to company results. On December 15, 2025, the insider acquired 15,394 performance stock units (PSUs) from a grant originally made on December 10, 2023, and 18,801 PSUs from a grant originally made on December 10, 2024. Each PSU represents the right to receive one share of Varex Imaging common stock if specific performance goals are met.
The PSUs earned for fiscal year 2025 reflect the achievement of performance criteria during that year. For the 2023 grant, the total PSUs earned will be certified after completion of fiscal year 2026, and for the 2024 grant after fiscal year 2027. In both cases, vesting also depends on the executive remaining employed through the applicable vesting date.
Varex Imaging Corp executive Mark S. Jonaitis, SVP and GM, X-Ray Sources, reported equity compensation activity dated December 10, 2025. Two restricted stock unit awards converted into a total of 12,599 shares of common stock, increasing his direct holdings before tax withholding. To satisfy associated tax obligations, 5,526 shares were withheld at a price of $11.70 per share, leaving him with 77,341 shares of common stock owned directly.
He also received a new grant of 26,041 restricted stock units, each convertible into one share of common stock. This grant is scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, while earlier RSU grants include vesting through December 10, 2027.
Varex Imaging Corp executive Andrew Hartmann, SVP and GM, Detectors, reported equity award transactions in the company’s common stock. On 12/10/2025, restricted stock units vested and converted into 4,664 and 7,935 shares of common stock, with each unit converting one-for-one into a share. To satisfy tax withholding from this vesting, 3,636 shares were withheld at a price of $11.7 per share. After these transactions, he directly owned 36,182 common shares.
Hartmann also continues to hold stock-based incentives through restricted stock units. Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027, and he held 7,936 restricted stock units following the reported transactions. In addition, he received a new grant of 26,041 restricted stock units on December 10, 2025, and held 26,401 restricted stock units afterward, scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, with shares delivered on each vesting date.
Varex Imaging Corp President and CEO, who is also a director, reported equity award activity in company stock dated 12/10/2025. Previously granted restricted stock units (RSUs) converted into 26,652 and 47,613 shares of common stock as they vested, and 32,566 shares were withheld at a price of $11.7 to satisfy tax withholding obligations related to this vesting. After these transactions, the reporting person directly holds 231,892 shares of common stock.
On the same date, the officer received a new grant of 156,250 RSUs, which are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Earlier RSU grants from December 10, 2021 and December 10, 2023 have already partially vested, with remaining portions scheduled to vest on December 10, 2027. Each RSU converts into one share of common stock upon vesting and delivery.
Varex Imaging Corp reported that its Chief Legal Officer received an equity award of 17,094 restricted stock units, each converting into one share of common stock. The award is reported as a Form 4 transaction dated December 10, 2025.
These restricted stock units are scheduled to vest in two equal installments, with 50% vesting on December 10, 2027 and the remaining 50% on December 10, 2029. On each vesting date, the underlying common shares will be delivered to the officer, providing long-term stock-based compensation tied to the company’s future performance.
Varex Imaging Corp’s chief human resources officer, Karen L. Aranki, reported equity award activity dated December 10, 2025. She acquired 6,665 shares of common stock upon the vesting of restricted stock units, which convert into common stock on a one-for-one basis. To cover tax withholding arising from this vesting, 1,923 shares were withheld and disposed of at a price of $11.7 per share, leaving her with 4,919 shares of common stock held directly afterward.
On the derivative side, 6,665 restricted stock units were settled into common stock, and she retained 6,666 restricted stock units from a grant originally made on December 10, 2023, which is scheduled to vest further on December 10, 2027. She also received a new grant of 21,875 restricted stock units on December 10, 2025, set to vest 50% on December 10, 2027 and 50% on December 10, 2029, with vested shares to be delivered on each vesting date.